• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在当代,越来越多的 cN0M0 前列腺癌患者在手术后被发现 pN+:一项关于疾病管理的国际欧洲调查结果。

The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease Management.

机构信息

Department of Urology, San Giovanni Battista Hospital, University of Torino, Torino, Italy.

Unit of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.

出版信息

Clin Genitourin Cancer. 2023 Jun;21(3):416.e1-416.e10. doi: 10.1016/j.clgc.2022.11.012. Epub 2022 Dec 5.

DOI:10.1016/j.clgc.2022.11.012
PMID:36609130
Abstract

INTRODUCTION

The urological community's opinion over the management of men being found with pathologically positive nodes (pN+) following radical prostatectomy (RP) performed with curative intent after preoperative negative conventional staging (cN0M0) has never been assessed. This remains crucial, especially considering the advent of novel imaging modalities. Our aim was to investigate the current opinion on management of pN+ cN0M0 prostate cancer (PCa) in the European urological community.

METHODS

Following validation, a 31-item survey, complying with the Cherries checklist, was distributed using a web link from December 2021 to April 2022 to 10 urological societies mailing list. Social media (Twitter, Facebook) were also used.

RESULTS

We received 253 replies. The majority were Urologists (96.8%), younger than 60 (90.5%); 5.2% did not have access to PET-scans; 78.9% believed pN+ is a multifaceted category; 10-years CSS was marked as 71 to 95% by 17.5%. Gold standard management was stated not being ADT by 80.8% and being RT±ADT by 52.3%. Early sRT±ADT was considered an option vs. aRT±ADT by 72.4%. In case of BCR 71% would perform and decide management based on PSMA-PET whilst 3.7% would not perform PSMA-PET. pN+ management is still unclear for 77.1%. On multivariate analysis PSMA-PET availability related to a lower and higher likelihood of considering aRT±ADT as standard and of considering early salvage versus aRT respectively (P < .05).

CONCLUSIONS

The Urological community has an acceptable awareness of pN+ disease and management, although it may overestimate disease aggressiveness. The majority consider pN+ PCa as a multifaceted category and rely on a risk-adapted approach. Expectant compared to immediate upfront management and new imaging modalities are increasingly considered.

摘要

简介

根治性前列腺切除术(RP)后术前常规分期(cN0M0)为阴性,而术后发现病理性阳性淋巴结(pN+)的患者,泌尿外科医生对其管理意见从未被评估过。这一点非常重要,尤其是考虑到新的影像学模式的出现。我们的目的是调查欧洲泌尿外科医生对 cN0M0 前列腺癌(PCa)伴 pN+患者的管理意见。

方法

在验证后,我们使用网页链接于 2021 年 12 月至 2022 年 4 月向 10 个泌尿外科协会的邮件列表分发了一份 31 项的调查问卷,该问卷符合 Cherries 清单。我们还使用了社交媒体(Twitter、Facebook)。

结果

我们收到了 253 份回复。大多数回复者是泌尿科医生(96.8%),年龄小于 60 岁(90.5%);5.2%的人无法获得 PET 扫描;78.9%的人认为 pN+是一个多方面的类别;17.5%的人认为 10 年 CSS 为 71%至 95%。80.8%的人认为标准治疗方法不是 ADT,52.3%的人认为是 RT±ADT。72.4%的人认为早期 sRT±ADT 是一种选择,而不是 aRT±ADT。如果发生生化复发,71%的人将进行 PSMA-PET 并根据 PSMA-PET 决定治疗方案,而 3.7%的人将不进行 PSMA-PET。77.1%的人认为 pN+的管理仍然不清楚。多变量分析显示,PSMA-PET 的可用性与考虑 aRT±ADT 作为标准治疗和考虑早期挽救治疗而非 aRT 的可能性呈负相关(P <.05)。

结论

泌尿外科医生对 pN+疾病及其管理有一定的认识,但可能高估了疾病的侵袭性。大多数人认为 pN+PCa 是一个多方面的类别,并且依赖于风险适应的方法。与立即进行治疗相比,他们更倾向于观察等待,并且越来越多地考虑新的影像学模式。

相似文献

1
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease Management.在当代,越来越多的 cN0M0 前列腺癌患者在手术后被发现 pN+:一项关于疾病管理的国际欧洲调查结果。
Clin Genitourin Cancer. 2023 Jun;21(3):416.e1-416.e10. doi: 10.1016/j.clgc.2022.11.012. Epub 2022 Dec 5.
2
The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study.术前PSMA PET/CT在cN0M0 pN+前列腺癌中的预后作用:一项多中心研究。
Clin Genitourin Cancer. 2024 Apr;22(2):244-251. doi: 10.1016/j.clgc.2023.11.006. Epub 2023 Nov 17.
3
How accurate is Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(Ga-PSMA PET/CT)在中高危前列腺癌根治性前列腺切除术前对原发性淋巴结分期的准确性如何?一项基于患者和淋巴结的分析研究。
Urol Oncol. 2022 Jan;40(1):6.e1-6.e9. doi: 10.1016/j.urolonc.2021.07.006. Epub 2021 Aug 13.
4
Site-specific relapse patterns of patients with biochemical recurrence following radical prostatectomy assessed by Ga-PSMA-11 PET/CT or C-Choline PET/CT: impact of postoperative treatments.基于 Ga-PSMA-11 PET/CT 或 C-Choline PET/CT 评估根治性前列腺切除术后生化复发患者的局部复发模式:术后治疗的影响。
World J Urol. 2021 Feb;39(2):399-406. doi: 10.1007/s00345-020-03220-0. Epub 2020 May 16.
5
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy.根治性前列腺切除术后 PSMA-PET/CT 引导挽救性放疗后淋巴结复发的结果。
Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1417-1428. doi: 10.1007/s00259-021-05557-z. Epub 2021 Oct 10.
6
Changes in Management After F-DCFPyL PSMA PET in Patients Undergoing Postprostatectomy Radiotherapy, with Early Biochemical Response Outcomes.前列腺癌根治术后放疗患者中,早期生化缓解结局下 F-DCFPyL PSMA PET 后管理的变化。
J Nucl Med. 2022 Sep;63(9):1343-1348. doi: 10.2967/jnumed.121.263521. Epub 2022 Jan 20.
7
Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.使用镓-68 前列腺特异性膜抗原正电子发射断层扫描术检测原发性和复发性前列腺癌的淋巴结转移和根治性前列腺切除术后的复发部位:对当前文献的综述。
BJU Int. 2020 Feb;125(2):206-214. doi: 10.1111/bju.14944. Epub 2019 Nov 29.
8
3-Year Freedom from Progression After Ga-PSMA PET/CT-Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter Trial.根治性前列腺切除术后生化复发男性患者经 Ga-PSMA PET/CT 分诊管理后 3 年无进展:一项前瞻性多中心试验的结果。
J Nucl Med. 2020 Jun;61(6):866-872. doi: 10.2967/jnumed.119.235028. Epub 2019 Nov 1.
9
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
10
Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.术前 3-T 多参数 MRI 和 Ga-PSMA PET/CT 扫描对前列腺癌根治性前列腺切除术和盆腔淋巴结清扫术病理结果的预测价值的组织学比较。
BJU Int. 2021 Jan;127(1):71-79. doi: 10.1111/bju.15134. Epub 2020 Sep 7.

引用本文的文献

1
Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET) in Initial Staging of Prostate Cancer Patients: The Beginning of a New Era.前列腺特异性膜抗原正电子发射断层扫描(PSMA-PET)在前列腺癌患者初始分期中的应用:新时代的开端。
Medicina (Kaunas). 2025 May 20;61(5):924. doi: 10.3390/medicina61050924.
2
Observation With or Without Subsequent Salvage Therapy for Pathologically Node-positive Prostate Cancer With Negative Conventional Imaging: Results From a Large Multicenter Cohort.对于传统影像学检查阴性的病理淋巴结阳性前列腺癌,观察与后续挽救性治疗的比较:来自大型多中心队列的结果
Eur Urol Open Sci. 2024 Aug 22;68:32-39. doi: 10.1016/j.euros.2024.06.016. eCollection 2024 Oct.